Type your tag names separated by a space and hit enter

Naftopidil for the treatment of lower urinary tract symptoms compatible with benign prostatic hyperplasia

Naftopidil for the treatment of lower urinary tract symptoms compatible with benign prostatic hyperplasia is a topic covered in the Evidence-Based Medicine Guidelines.

To view the entire topic, please or purchase a subscription.

Evidence Central is an integrated web and mobile solution that helps clinicians quickly answer etiology, diagnosis, treatment, and prognosis questions using the latest evidence-based research. Explore these free sample topics:

Evidence Central

Citation

* When formatting your citation, note that all book, journal, and database titles should be italicized* Article titles in AMA citation format should be in sentence-case
TY - ELEC T1 - Naftopidil for the treatment of lower urinary tract symptoms compatible with benign prostatic hyperplasia ID - 454639 BT - Evidence-Based Medicine Guidelines UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/454639/all/Naftopidil_for_the_treatment_of_lower_urinary_tract_symptoms_compatible_with_benign_prostatic_hyperplasia PB - Duodecim Medical Publications Limited DB - Evidence Central DP - Unbound Medicine ER -